Concepedia

Kelly Connolly

KC

Statistics

Publications

11

Citations

570

H-Index

11

Active since

2000

Affiliations

Tufts University(Current)

Millennium Engineering and Integration (United States)

Boston University

Kelly Connolly is an author at Tufts University specializing in pharmacology, neuroscience, and medicine.

Publications per year

2000–2021

11

Publications

11

Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer

Steven Langston, Stephen Grossman, Dylan B. England et al. · Journal of Medicinal Chemistry · 2021 · 208 citations · Full text

, , +11

Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids

Margery C. Beinfeld, Kelly Connolly · Neuroscience Letters · 2001 · 82 citations

, , +14

Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice

John Byrnes, Stefan B. Gross, C Ellard et al. · Inflammation Research · 2009 · 69 citations

, , +14

Biological characterization of MLN944: A potent DNA binding agent

Darshan S. Sappal, A. Kathleen McClendon, James Fleming et al. · Molecular Cancer Therapeutics · 2004 · 52 citations · Full text

, , +10

Distribution and colocalization of cholecystokinin with the prohormone convertase enzymes PC1, PC2, and PC5 in rat brain

Brian Cain, Kelly Connolly, Alissa Blum et al. · The Journal of Comparative Neurology · 2003 · 37 citations

, , +14

1–5 of 11